Sharp Therapeutics Corp. (TSXV:SHRX)
3.950
-0.250 (-5.95%)
At close: Nov 18, 2025
Sharp Therapeutics Statistics
Total Valuation
TSXV:SHRX has a market cap or net worth of CAD 118.54 million. The enterprise value is 116.01 million.
| Market Cap | 118.54M |
| Enterprise Value | 116.01M |
Important Dates
The last earnings date was Friday, November 28, 2025.
| Earnings Date | Nov 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:SHRX has 30.01 million shares outstanding.
| Current Share Class | 30.01M |
| Shares Outstanding | 30.01M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +1.05% |
| Owned by Insiders (%) | 3.49% |
| Owned by Institutions (%) | 0.70% |
| Float | 16.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 60.11 |
| P/TBV Ratio | 60.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -25.04 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.80, with a Debt / Equity ratio of 0.91.
| Current Ratio | 4.80 |
| Quick Ratio | 4.62 |
| Debt / Equity | 0.91 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -20.01 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -150.47% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -1.47 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 2.57 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 54.25 |
| Average Volume (20 Days) | 4,000 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.45M |
| Pretax Income | -4.63M |
| Net Income | -4.63M |
| EBITDA | -5.48M |
| EBIT | -5.45M |
| Earnings Per Share (EPS) | -0.15 |
Balance Sheet
The company has 2.78 million in cash and 1.80 million in debt, giving a net cash position of 976,892 or 0.03 per share.
| Cash & Cash Equivalents | 2.78M |
| Total Debt | 1.80M |
| Net Cash | 976,892 |
| Net Cash Per Share | 0.03 |
| Equity (Book Value) | 1.97M |
| Book Value Per Share | 0.07 |
| Working Capital | 2.28M |
Cash Flow
| Operating Cash Flow | -7.41M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSXV:SHRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -3.91% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 27, 2025. It was a reverse split with a ratio of 0.1.
| Last Split Date | Jan 27, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |